Trump administration pick for Health and Human Services department could cause rise in preventable disease, health expert ...

Scott Gottlieb said he’s worried that Trump’s pick to run HHS, Robert F. Kennedy Jr., will follow through on past antivaccine ...

Scott Gottlieb, who served as commissioner of the Food and Drug Administration (FDA) during President-elect Trump’s first ...

Mean duration of Crohn's disease was 7.4 years. Nearly half (48.5%) had previous biologic therapy failure, 45.7% had previous ...

See the new treatment that will break a Pfizer monopoly on a drug for heart disease.

Pfizer (NYSE:PFE) discovers, develops, manufactures, markets, distributes and sells biopharmaceutical products in the United ...

One stock that just can't seem to catch a break of late is Pfizer (NYSE: PFE). Given how well Pfizer has performed in recent ...

Despite Pfizer 's ( PFE 0.23%) recent struggles with falling earnings and a bid by an activist investor to unseat its ...

Pfizer's high initial dividend yield, solid ratings, and promising pipeline make it a potentially undervalued investment. See ...

Stocks knocked down in the first ten months of the year often suffer further damage as people sell for tax losses. But they ...

Once a controversial European depression treatment that never made it to the U.S. | The treatment, which was once a Pfizer ...